Abstract
H3.3, the most common replacement variant for histone H3, has emerged as an important player in chromatin dynamics for controlling gene expression and genome integrity. While replicative variants H3.1 and H3.2 are primarily incorporated into nucleosomes during DNA synthesis, H3.3 is under the control of H3.3-specific histone chaperones for spatiotemporal incorporation throughout the cell cycle. Over the years, there has been progress in understanding the mechanisms by which H3.3 affects domain structure and function. Furthermore, H3.3 distribution and relative abundance profoundly impact cellular identity and plasticity during normal development and pathogenesis. Recurrent mutations in H3.3 and its chaperones have been identified in neoplastic transformation and developmental disorders, providing new insights into chromatin biology and disease. Here, we review recent findings emphasizing how two distinct histone chaperones, HIRA and DAXX, take part in the spatial and temporal distribution of H3.3 in different chromatin domains and ultimately achieve dynamic control of chromatin organization and function. Elucidating the H3.3 deposition pathways from the available histone pool will open new avenues for understanding the mechanisms by which H3.3 epigenetically regulates gene expression and its impact on cellular integrity and pathogenesis.
Similar content being viewed by others
Introduction
The eukaryotic genome forms a chromatin structure that consists of regularly positioned nucleosomes along the genome. This structure enables cells to harbor ~3 billion bp long genomic DNA (in the case of human) packed within the nucleus and stably propagate while preventing the DNA from becoming twisted and tangled. Chromatin exists in a default condensed state that restricts the access of biological macromolecules and safeguards the genome. However, there are time- and space-dependent processes that open the chromatin structure and allow various biological functions, such as DNA replication, transcription, DNA damage repair, and recombination, to occur1. As a building unit for chromatin, the nucleosome core structure consists of 146 bp of DNA wrapped around a histone octamer assembled from the two copies of each of the core histones H2A, H2B, H3, and H42. Histones regulate the chromatin structure through posttranslational modifications (PTMs), such as acetylation, methylation, phosphorylation, and ubiquitination3. Most nucleosomes in the cell are composed of these canonical histones. However, cells can express alternative forms of H2A, H2B, and H3, called noncanonical histone variants, which are incorporated into nucleosomes at specific genomic loci, indicating that they have distinct functions. The supply, exchange, deposition, and eviction of histones occur in DNA through the assembly and disassembly of nucleosomes, which is mediated by histone chaperones specific to canonical or noncanonical variants4. To ensure stable propagation of the genome and dynamic utilization of genetic information, histone chaperones play a pivotal role in chromatin dynamics and histone deposition on DNA. Here, we focus on two H3.3-specific histone chaperones that regulate the H3.3 landscape.
H3.1/H3.2 vs. H3.3
Histone H3 has three representative variants that are evolutionally conserved: H3.1, H3.2, and H3.3 (Fig. 1a). Canonical forms (histone H3.1 and H3.2) are encoded from multiple copies of histone gene clusters, predominantly expressed during the S phase, and globally incorporated into DNA in a replication-dependent (RD) manner. RD-H3 deposition stably maintains nucleosome levels to ensure genome and epigenome integrity during cell division. In contrast, H3.3, a noncanonical variant, is encoded by two independent genes in humans, H3F3A and H3F3B, expressed throughout the cell cycle. H3.3 is incorporated into chromatin in a DNA replication-independent (RI) manner whenever histone turnover is necessary, such as during transcription and DNA damage repair4,5. Consequently, H3.1/H3.2 is used globally as a default substrate for chromatin synthesis and can be replaced by H3.3 at genomic locations where chromatin assembly and disassembly are actively occurring. In this manner, dividing cells are thought to maintain approximately 10–20% H3.3 nucleosomes, which increases to ~90% in postmitotic cells6. Although most H3.3 nucleosomes are assembled via the RI pathway, a recent study showed that preexisting H3.3 nucleosomes within the parental DNA strands can also be inherited by the daughter strands during S phase in an RD manner7. Yeast has one type of H3 that possesses characteristics from both H3.1 and H3.3. This H3 type is deposited through both the RD and RI pathways and plays dual functions.
H3.3 performs seemingly contradictory functions at different genetic loci. Initial studies discovered H3.3 within actively transcribed regions, promoting transcription through processes such as hyperacetylation of lysine (K) residues and methylation of H3K4 (H3K4me1/2/3), H3K36 (H3K36me3), and H3K79 (H3K79me3). Later studies revealed that H3.3 localized in heterochromatin suppresses transcription through processes such as K hypoacetylation and trimethylation of H3K9 (H3K9me3) and H4K20 (H4K20me3). Since gene expression programs are specific to the developmental lineage and differentiation status of cells, the H3.3 distribution profile can mirror distinct gene expression programs specific to different cell types (H3 barcode hypothesis)8. In this regard, the H3.3 mark is critical to maintaining cellular identity, acting as a roadblock that needs to be removed before differentiation and reprogramming can occur.
Although they have distinct functions, H3.3 differs from H3.1 by only five amino acids (S31, A87, I89, G90, S96) and from H3.2 by only four amino acids (S31, A87, I89, G90) (Fig. 1b). Three residues, A87, I89, and G90, known as the AIG motif, reside in the nucleosome core domain and determine the deposition route through direct contact with H3.3-specific histone chaperones9,10,11. In addition, H3.3-specific S31 phosphorylation (S31P) is important for maintaining chromatin and cell survival12. Interestingly, other residues known to undergo extensive PTMs for the regulation of chromatin functions are all conserved among variants. Two representative H3/H4 histone chaperones involved in the recognition and regulated deposition of H3.3 through the RI pathway are histone regulator A (HIRA) and death domain-associated protein (DAXX)13,14. In general, HIRA is involved in H3.3 deposition in euchromatin, such as actively transcribed gene bodies and regulatory elements, while DAXX governs H3.3 deposition in heterochromatin, such as pericentromeres, retrotransposons, and subtelomeric regions14.
There are several chaperones that load H3 onto DNA: CAF-1, NASP, and ASF1 for bulk nucleosome assembly and HJURP for the creation of specific chromatin domains. The CAF-1 complex consists of CHAF1A (p150), CHAF1B (p60), and RBBP4 (p48) in humans and participates in the assembly of nucleosomes using newly synthesized H3.1 and H3.2 during DNA replication and DNA damage repair4,5. NASP is involved in maintaining the soluble H3/H4 pool for histone homeostasis15. ASF1 (ASF1a, ASF1b) and NASP transport H3 from the H3/H4 reservoir to CAF-1 or HIRA without variant specificity. HJURP in humans is the histone chaperone of the centromere H3 (CenH3) variant CENP-A and is exclusively involved in the assembly of centromere nucleosomes16. The following sections summarize key findings on the dynamic regulation of H3.3 deposition and the control of chromatin functions via the HIRA and DAXX chaperones.
HIRA vs. DAXX: two important players in the dynamic regulation of the H3.3 landscape
HIRA and DAXX are two principal chaperones that mediate the selective incorporation of H3.3 into nucleosomes in defined chromatin domains (Figs. 1a and 2a). Both chaperones assemble nucleosomes independently of DNA synthesis and act as a component of a multisubunit complex while interacting with various auxiliary proteins. They mediate the targeted incorporation of H3.3/H4 into nucleosomes at disparate locations with different outcomes. Furthermore, many studies have raised the possibility that these two chaperones may collaborate, complement, or compete with one another, as they utilize the same histone substrate from the limited pool of H3.3. Upstream biological signals and interactions with protein partners, noncoding RNAs, or genomic features might contribute to the elaborate regulation and balance of these two representative H3.3 deposition chaperone proteins.
HIRA complex
The HIRA complex is composed of HIRA, Calcineurin-binding protein 1 (CABIN1), and Ubinuclein 1 or 2 (UBN1/2) and cooperates with ASF1 to deposit H3.317,18,19 (Fig. 2a, b). The HIRA complex may not necessarily be constructed through a 1:1 stoichiometric interaction. Recent biochemical and structural analysis showed that the HIRA subunit forms a stable homotrimer in vitro that interacts with two molecules of CABIN1 in a 3:2 stoichiometry20. Three functionally important domains of the HIRA protein are involved in H3/H4 binding and chromatin remodeling. Specifically, the N-terminus of the HIRA protein contains the WD40 domain, which is made up of seven WD40 repeats forming a beta-propeller structure. This WD40 domain has been shown to mediate histone binding by interacting with UBN1/UBN2, which recognize H3.3, and RBBP4 (p48), which binds H3/H4 within CAF-1 complexes as well21. The central B domain of HIRA is responsible for binding to the H3/H4 chaperone ASF1. The interaction between the B domain and ASF1 is crucial to recruiting ASF1 to chromatin and facilitating the incorporation of H3/H4 into newly formed nucleosomes. The Hir (histone regulatory) domain in the C-terminus is responsible for the interaction with CABIN121. Domain features show that HIRA plays a central role in recruiting these proteins to chromatin and promoting chromatin remodeling through H3.3/H4 deposition. In addition, HIRA and UBN1/2 possess DNA-binding activities that might facilitate histone deposition on nucleosome-free DNA as a gap-filling mechanism22,23,24. Moreover, the chaperoning activity and subnuclear localization of HIRA can be modulated by various PTMs. For example, HIRA phosphorylation can cause its translocation to promyelocytic leukemia protein (PML) nuclear bodies (PML-NB) upon the initiation of human primary cell senescence25. HIRA phosphorylation also regulates H3.3 deposition during myogenesis26. The O-GlcNAcylation of HIRA is linked to the efficiency of H3.3 nucleosome assembly27. HIRA is also polyADP-ribosylated for the maintenance of telomeric chromatin under certain conditions28.
UBN1 and UBN2 are paralogs that play both similar and distinct roles in gene regulation and are alternatively present in the HIRA complex. Both UBN1 and UBN2 bind specifically to the H3.3/H4 dimer independently of the HIRA subunit through the evolutionarily conserved Hpc2-related domain (HRD)10,11. UBN1 and UBN2 specifically recognize A87 and G90 within the H3.3 AIG motif, endowing the HIRA complex with H3.3 specificity. The N-terminal domain (NHRD) of UBN1/2 is involved in the HIRA WD40 interaction, and the middle domain and its vicinity have UBN-UBN dimerization and DNA-binding activity, suggesting that UBN1 and UBN2 associate with DNA and mediate (H3.3/H4)2 tetramer formation prior to chromatin deposition24. It appears that UBN1 and UBN2-containing HIRA complexes can cooperate in depositing H3.3/H4 across the genome in transcriptionally active regions, such as cis-regulatory elements of neural developmental genes, during mouse embryonic stem cell (ESC) differentiation11.
CABIN1 was independently identified as a repressor of MEF2 and calcineurin-mediated signaling in immune cells29, but its function within the HIRA complex remains unclear. Considering that Cabin1 is a large protein of 2220 amino acid residues and is needed for complex stability, it could serve as a scaffolding platform for complex integrity17. Furthermore, given that CABIN1 is involved in the recruitment of mSin3/histone deacetylases (HDACs) and histone methyltransferases (HMTs), such as SUV39H1, in immune cells30, it could play a potential role in HIRA complex-mediated silencing and chromatin compaction. In fact, the H3.3 and HIRA complex is involved in the heterochromatinization of the genome in senescent human cells17,31,32.
ASF1 interacts with HIRA for H3.3 supply
ASF1 is an evolutionally conserved H3/H4 histone chaperone working at the interface of the RD and RI deposition pathways5. Yeast has a single type of Asf1, while in higher eukaryotes, ASF1 further diverges into ASF1a and ASF1b paralogs. ASF1b is responsible for supplying newly synthesized H3.1/H4 or H3.2/H4 dimers to the CAF-1 complex at the site of DNA replication, while ASF1a preferentially transfers new H3.3/H4 to HIRA and/or UBN1/2 by directly binding to the B domain of the HIRA protein11,33. The structural analysis of ASF1 suggested that it binds to the H3/H4 dimer without contacting the H3.3 AIG motif34,35. Although ASF1 itself does not provide H3 variant specificity, it is critical in linking H3/H4 to downstream chaperones, implying that the selection of H3 variants for transfer could be in part dependent on the abundance and availability of the H3 type from the histone pool. Furthermore, the ASF1-H3/H4 complex structure suggests that ASF1 is structurally incompatible with (H3/H4)2 tetramer binding, providing functional insights into its additional role in the disintegration of preexisting nucleosomes into H3/H4 dimers34,36.
Notably, each H3 binding protein (HIRA, UBN1/2) in the HIRA complex and ASF1 coordinately mediate the continuous flow of H3.3/H4 onto DNA. As HIRA and ASF1 do not have H3.3 specificity, UBN1/2 may be the determinant of H3.3 specificity, while ASF1 can contribute to widening the choice of H3 type. ASF1 may be responsible for splitting the (H3/H4)2 tetramer into H3/H4 dimers, allowing histone turnover through the simultaneous assembly and disassembly of nucleosomes. For example, the recycling of old H3.3 from preexisting nucleosomes is mediated by ASF1/HIRA during transcription37, implying that these chaperones could function in a highly coordinated manner to modulate the usage of old and new H3/H4 during polymerase II transcription38.
DAXX complex
DAXX is an H3.3-specific chaperone that cooperates with the alpha-thalassemia/mental retardation X-linked (ATRX) protein in RI nucleosome assembly. DAXX and ATRX are responsible for incorporating H3.3 into repetitive genomic regions such as pericentromeres, telomeres, and retrotransposons. Moreover, DAXX and ATRX modulate gene silencing and genome stability by chromatin compaction39. DAXX has several important domains that interact with many different protein partners, allowing it to participate in various cellular processes (Fig. 2c). First, DAXX has a highly conserved histone-binding domain (HBD) that provides H3.3 specificity9,13,40. Structural and biochemical studies have shown that the H3.3 AIG motif interacts with the DAXX HBD, whereby A87 is located in a shallow hydrophobic pocket, and G90 remains in the hydrophilic region of the HBD9,13. The DAXX HBD wraps around H3.3/H4 using an extended α-helical conformation, competing with histone–DNA and histone–ASF1 contacts, suggesting that the DAXX/H3.3/H4 complex prefers the H3.3/H4 dimer to the tetramer and is incompatible with cobinding with ASF140. These hydrophobic, electrostatic, and hydrogen bond interactions contribute to stable complex formation; otherwise, DAXX could undergo destabilization upon loss of H3.3 contact41.
The N-terminal four helical bundle (4HB) domain is a structurally conserved motif that mediates protein–protein interactions, including ATRX. Specifically, the 4HB of DAXX interacts hydrophobically with the DAXX binding motif (DBM) of ATRX41. This interaction facilitates the formation of a stable DAXX–ATRX complex, which is then anchored to a H3K9me3-marked region for targeted H3.3 deposition into heterochromatin. The SUMO-interaction motif (SIM) at the N- and C-terminal ends interacts with SUMO-modified proteins. SUMOylation is the PTM in which the SUMO peptide is covalently attached to various target proteins, including PML. The SIM domain of DAXX binds specifically to SUMO-modified PML and contributes to its localization in PML-NBs42. Moreover, DAXX possesses an additional domain known as the PML-NB targeting region that aids in its localization. These characteristics ensure DAXX accumulation in PML-NBs and the formation of a stable DAXX/ATRX/H3.3 ternary complex.
ATRX is a main binding partner of DAXX, providing many heterochromatin-associated features. ATRX has two highly conserved domains: the ADD (ATRX-DNMT3-DNMT3L) and ATPase/helicase domains43. Many mutations associated with ATRX syndrome are predominantly located in these two domains, implying that the molecular function of ATRX largely depends on these domains. Importantly, ADD is responsible for the specific recognition of H3K9me3 in the presence of unmethylated H3K4 and the stable association with H3K9me3-marked chromatin domains44. The recruitment of ATRX to heterochromatin is further reinforced by interaction with HP1 through the PxVxL motif45. HP1 plays a crucial role in the lateral spreading of H3K9me3, chromatin compaction, and heterochromatin compartmentalization46. The ATPase/helicase domain is necessary for the translocation of ATRX along DNA using the energy of ATP hydrolysis. It alters DNA-histone contact within a nucleosome to facilitate the insertion of H3.3, in coupled with DAXX. Furthermore, ATRX directly binds MeCP2 through its C-terminal helicase domain, which is important for pericentromeric localization, heterochromatin organization47, and suppression of imprinting genes in the mouse brain48,49.
Importantly, ATRX can form facultative heterochromatin through H3K27me3, independent of DAXX. Polycomb repressive complex 2 (PRC2) comprises EZH2, EED, SUZ12, and RBAP46/48, where EZH2 is the HMT responsible for H3K27me3. ATRX recruits PRC2 through interaction with EZH2 for H3K27 methylation50. In addition, recent studies revealed that ATRX functions as an RNA-binding protein. Two RNA-binding domains are mapped on ATRX: one near the N-terminus and the other within the ATPase/helicase domain50,51. RNA binding contributes to the spatial location of ATRX and its binding proteins. For instance, during X chromosome inactivation (XCI), ATRX directly binds to Xist, a noncoding RNA (ncRNA), and mediates the spreading of EZH2-mediated H3K27me3 along the inactive X chromosome. Similarly, DAXX can function independently of ATRX. It suppresses endogenous retroviruses (ERVs) in mouse ESCs in a distinct complex containing SETDB1 (KMT1E), the corepressor protein KAP1 (TRIM28), and HDAC141.
PML facilitates DAXX/ATRX-mediated H3.3 deposition
The PML body is a subnuclear structure comprised of a shell of PML proteins and many other proteins (>100) enriched inside52. PML bodies are associated with the buffering, storage, and PTM of various proteins and are involved in a wide range of cellular functions, including cell growth, apoptosis, antiviral resistance, senescence, and DNA damage responses52. In the nucleus, DAXX brings the newly synthesized H3.3/H4 dimer to PML-NBs, which is facilitated by ASF1A53. SUMOylation and the SUMO-SIM interaction between PML and DAXX lead to the accumulation of DAXX and ATRX in PML-NB42,54. H3.3/H4 is transferred to the DAXX/ATRX complex in PML-NB before loading onto defined chromatin domains53,55,56. Therefore, in chromatin biology, PML-NBs serve as an important insoluble compartment of H3.3/H4. Furthermore, PML is associated with heterochromatin, such as telomeres, and is involved in the maintenance of chromatin with H3K9me3 and H3K27me357, emphasizing its role as a platform for the targeted supply of repressive H3.3 in these regions. Recent studies suggest that the fate of H3.3 is predetermined by the H3K9 methyl mark before nucleosome assembly. That is, DAXX promotes H3K9me3 in new H3.3/H4 prior to deposition via interaction with SUV39H1 and SETDB1 in a histone- and/or SUMOylated protein-dependent manner58, although whether this occurs in the context of PML-NBs remains to be revealed. Overall, the multitude of protein–protein interactions with the DAXX/ATRX complex ultimately promotes H3.3 loading and its role in gene silencing and chromatin compaction in repetitive genome regions with repressive histone marks such as K hypoacetylation, H3K9me3, H3K27me3, and H4K20me3.
Distinct and overlapping functions of HIRA and DAXX in chromatin organization and gene regulation
Transcription-permissive chromatin and gene activation by HIRA complex
Several studies have demonstrated that HIRA and H3.3 nucleosomes are primarily associated with euchromatin and normal transcriptional regulation, including de novo transcription and long-term duration. In addition, the loss of HIRA and/or H3.3 has been linked to widespread transcriptional dysregulation and diminished recruitment of transcription factors. Meanwhile, chromatin accessibility either increases or decreases with the loss of HIRA/H3.3, depending on the genomic and cellular contexts59,60,61.
Many studies suggest that H3.3-containing nucleosomes are more susceptible to disruption than their conventional counterparts and become even more fragile when nucleosomes contain both H3.3 and H2A.Z62,63,64. H2A.Z is a variant of H2A that is incorporated into nucleosomes in an RI manner63. H3.3/H2A.Z double variant nucleosomes are enriched at highly transcribed gene bodies and regulatory regions such as promoters and enhancers62,63,64. This intrinsic susceptibility of the H3.3 nucleosome and/or the unfolding features of H3.3-containing chromatin structure may, in part, contribute to the dynamic control of chromatin accessibility to facilitate transcription factor binding and histone modifications that activate transcription59,65. However, given that both the HIRA complex and H3.3 cooperate with many other chromatin factors, the question remains to what extent such physical properties of the H3.3 nucleosome can contribute to chromatin states permissive to transcriptional events.
HIRA participates in multiple stages of transcription (Fig. 3a). During initiation, it interacts with a single-stranded DNA-binding protein, RPA, on promoters and enhancers to mediate H3.3 deposition and transcription66. The locally melted regulatory DNA and the transcription bubble are active sites of histone turnover and can be coupled to HIRA-mediated H3.3 deposition. Moreover, HIRA has been shown to couple with a SWI/SNF family chromatin remodeler, CHD1, during paternal pronuclear formation to ensure H3.3 nucleosome assembly and spacing67,68. Cooperation between HIRA and CHD1 also mediates H3.3 incorporation and global transcription in Drosophila adult brain cells69. Chd2, a closely related member of the SNF2 family, is also involved in the H3.3 marking of myogenic regulatory regions, where HIRA plays a role in muscle gene regulation and cell fate determination through H3.3 deposition70,71. The recruitment of HIRA through crosstalk with various transcription factors indeed enables the enrichment of H3.3 in promoters for gene activation72. Notably, H3.3 is needed for enhancer acetylation (H3K27ac) and activation of p300 during histone turnover, chromatin remodeler binding for transcription accuracy, rapid induction of inflammatory genes in mouse macrophages, mouse ESC differentiation, and Xenopus gastrulation59,60,61,70,71,73. HIRA is also involved in priming damaged loci by H3.3 deposition to facilitate transcriptional recovery after DNA damage repair74. These findings are consistent with high rates of H3.3 turnover in transcriptionally active sites75.
During elongation, HIRA binds to interferon-responsive genes to incorporate H3.3 into actively transcribed gene bodies76. HIRA occupancy was dependent on NSD2 (WHSC1), a H3K36 HMT that recruits BRD4 and the positive elongation factor P-TEFb to polymerase II, facilitating transcriptional elongation. Cooperation between H3.3K36me3 and S31P controls transcriptional elongation and RNA processing. For instance, ZMYND11 is a transcriptional corepressor that binds H3.3K36me3 within gene bodies and suppresses transcription elongation77,78. To promote transcription upon stimuli, H3.3 S31 is phosphorylated, which stimulates SETD2 activity, increases H3K36me3 levels, and displaces ZMYND11 for efficient gene expression in mouse macrophages79. During transcription elongation, the HIRA complex travels throughout the entire gene body together with polymerase II22,76. Indeed, HIRA KO decreases the H3K36me3 level, serine 2 phosphorylation of the polymerase II C-terminal domain (CTD), and the recruitment of elongation factors (ZMYND11, BRD4, CDK9) at the IgH locus in human B cells61. Altered CTD phosphorylation could affect transcription and mRNA processing80,81. Moreover, the polymerase elongation rate over chromatin structure can influence the cotranscriptional regulation of splicing82. Therefore, it is intriguing that the H3.3 level affects polymerase II elongation and cotranscriptional splicing and is associated with altered exon usage and intron retention after impairment83.
Heterochromatinization and gene silencing by DAXX/ATRX
DAXX/ATRX and H3.3 nucleosomes have been linked to gene silencing and constitutive heterochromatin formation in repetitive genomic regions (Fig. 3b). These repetitive DNA elements are heterochromatinized early during embryonic development to protect the genome from aberrant transcription and recombination. The ADD domain of ATRX and its interaction with HP1α facilitate DAXX-mediated H3.3 deposition and subsequent methylation of H3K9 by SETDB1 and SUV39H1/2 at these loci. The intermolecular interactions of HP1α-SUV39H-H3K9me3 promote the expansion of the heterochromatin domain. Although the precise role of the H3.3 nucleosome in these repressive chromatin contexts is largely unknown, it may affect heterochromatinization by permitting the limited local transcription of repeat elements. It is well-documented that many chromatin-associated proteins rely on ncRNAs for their proper localization84. Despite its heterochromatic nature, a small amount of RNA is transcribed from the pericentromeric region, which in turn facilitates heterochromatin retention of SUV39H1/285,86,87 and HP1α88,89 to maintain the heterochromatin state. H2A.Z, which forms labile double variant nucleosomes with H3.3, was also shown to cooperate with HP1α to regulate heterochromatin domains90. ATRX, MeCP2, and satellite RNA transcripts cooperate for heterochromatin organization in neurons47,91. H3.3 can thus be associated with the local transcription of repeated regions. Along this line, accumulation of DAXX/ATRX in chromocenters and concomitant induction of pericentromeric transcripts are evident with pericentromeric/centromeric DNA clustering during myogenesis92,93 and neural differentiation47,91. Recent studies on biomolecular condensation have applied the concept of phase separation to the process of heterochromatinization of genomic repeats, where many proteins with internally disordered regions (IDRs), RNA binding, and RNA transcripts play a pivotal role through transient, weak, and multivalent intermolecular interactions94.
H3.3 is involved in the silencing of endogenous retroviral elements (ERVs) in mouse ESCs95,96. ERVs such as MLV, IAP, and MusD are enriched with H3.3 and marked by H3K9me3 and H4K20me3, where their silencing is dependent on H3.3, SETDB1, and KAP1. SETDB1/KAP1 is independently known to cooperate with Kruppel-associated box zinc finger proteins (KRAB-ZFP) to silence transposable elements and imprinting genes based on the DNA-binding ability of KRAB-ZFP97. These reports showed that the recruitment of DAXX, H3.3, and KAP1 is codependent and required for H3K9me3 and subsequent repression of ERV expression and transposition, suggesting a functional interplay between H3.3 loading and H3K9me3 for heterochromatin establishment in ERVs95,96. Morc3 ATPase was also discovered by genome-wide screening, showing that it is an upstream regulator of H3.3 loading and ERV silencing through SUMO-SIM-mediated DAXX interaction98. However, it is unclear whether H3.3 nucleosomes and the chaperoning activity of DAXX are absolutely needed for the heterochromatinization of ERVs. Given ATRX-independent ERV suppression and the effect of H3.3 on DAXX stabilization41, the H3.3 profile might coincide with H3K9me3 without direct involvement of H3.3 in repressive nucleosome formation. However, the requirement of H3.3 nucleosomes and the functional crosstalk between KAP1 and H3.3 loading suggest that H3.3 might be necessary to suppress retroviral gene expression in mouse ESCs96. In line with this hypothesis, such interstitial heterochromatin regions in ESCs exhibit highly dynamic properties and rapid histone exchange, suggesting that H3.3 may control heterochromatin accessibility for efficient ERV repression99,100.
Plasticity and redundancy in H3.3 chaperone functions
Two H3.3 chaperone complexes perform unique functions in chromatin organization and gene regulation despite both modulating the H3.3 landscape. The unique functions are achieved by the tight control of the H3.3 supply via the preservation of H3.3/H4 in two spatially segregated compartments: the H3.3 pool in soluble (ASF1-HIRA pathway) and insoluble (PML-NB-DAXX pathway) contexts. However, accumulating reports show significant functional crosstalk between HIRA and DAXX (Fig. 3).
The newly synthesized H3.1/H4, H3.2/H4, and H3.3/H4 dimers are sequentially transferred through multiple protein chains to ASF1, which acts as a traffic hub for a stable supply of H3/H4 to the downstream chaperones CAF-1, HIRA, and DAXX. ASF1 has been shown to interact directly and indirectly with all three chaperones and contributes to functional crossover, likely due to its role in the maintenance and distribution of H3/H4 into distinct compartments4,5. Interestingly, HIRA, but not DAXX, can take the place of CAF-1 to maintain chromatin integrity during DNA replication. In instances where CAF-1 activity is compromised, HIRA can compensate by incorporating H3.3 into a broad range of genomes22,101. Furthermore, CenH3 overexpression leads to DAXX-dependent deposition of H3.3/H4-CenH3/H4 heterotetramers into euchromatin102, showing that DAXX has a certain level of flexibility in H3 binding and routing. Interestingly, ASF1 also assists DAXX/ATRX-mediated H3.3 deposition through PML-NBs. For example, ASF1 facilitates H3.3 enrichment in PML-NBs. The Drosophila DAXX-like protein (DLP) associated with ASF1 for H3.3 deposition in heterochromatin103. Consistently, proteomic analysis of the histone chaperone interaction network indicated that ASF1b acts partially upstream of DAXX for H3.3 deposition in heterochromatin58. Notably, the absence of DAXX improves the nucleosomal insertion of H3.3 through HIRA and CAF-153, implying that two distinct compartments are interconnected via ASF1, which supervises the relative partitioning of H3.3/H4 as a distribution hub.
Furthermore, DAXX sequestration within PML-NBs is dynamically regulated under various circumstances, which can affect the H3.3 landscape. For example, upon heat shock or stress, the translocation of DAXX from PML-NB to centromeres and pericentromeres is increased to stimulate H3.3 deposition and RNA transcription104. In contrast, PML loss was shown to change the H3.3 deposition route from DAXX/ATRX-dependent to HIRA-dependent and the epigenetic features from H3K9me3 to H3K27me3 in PML-associated heterochromatin56. Moreover, DEK, a PML-associated protein, has been shown to control the balance of H3.3 loading between DAXX/ATRX and HIRA in somatic and ES cells. DEK depletion shifted the balance from DAXX/ATRX to HIRA, resulting in H3.3 occurring widely in the chromosome arms away from telomeres105. These studies suggest that PML-NBs and associated proteins play a role in the fine control of the H3.3 landscape by modulating interactions between H3.3 and its chaperoning partners. In addition, HIRA and ASF1 have been shown to accumulate in PML-NBs under certain conditions such as senescence18,31 and immune response to viral infection106,107,108,109. The unexpected concomitance of HIRA and DAXX in PML-NBs suggests their overlapping functions in chromatin regulation.
HIRA and DAXX function in chromatin function and gene regulation is somewhat redundant. Recent findings revealed that the HIRA complex is responsible for silencing specific genomic loci, such as MERV-L, by regulating H3.3 deposition and H3K9 methylation (Fig. 3b)110. In ESCs, histone chaperones may target and repress different classes of ERVs; HIRA regulates class III ERVs, while DAXX/ATRX regulates class I and II ERVs95. Furthermore, PML, DAXX, and HIRA are involved in the epigenetic repression of viral genes. Notably, HIRA relocalizes to PML-NBs after viral infection to promote heterochromatinization by H3.3 loading, viral gene silencing, and antiviral immunity106,107,108. During the inflammatory response, HIRA accumulates in PML-NB in a SUMO-dependent manner to mediate interferon-stimulated gene expression by H3.3 loading109, although it remains to be elucidated whether SUMOylation and PML-NB localization are necessary for genomic targeting. In addition, DAXX and HIRA exhibit a certain level of redundancy; for example, the DAXX/ATRX and HIRA complexes can partially compensate for each other’s absence in H3.3 deposition on the viral genome106. Similarly, HIRA can compensate for the loss of DAXX/ATRX by depositing H3.3 onto telomeric heterochromatin in alternative lengthening of telomeres (ALT) cancer cells28. Furthermore, DAXX/ATRX is implicated in gene activation. DAXX drives H3.3 deposition in regulatory regions of activity-responsive genes upon neuronal activation111. ATRX also upregulates the expression of ancestral pseudoautosomal region (aPAR) genes in the mouse forebrain by facilitating transcriptional elongation through G-rich sequences112. ATRX has a high affinity for G-quadraplexes, often formed in telomeres and gene regulatory regions upon DNA melting. Here, ATRX mediates H3.3 deposition to dissolve intragenic G-quadruplexes and facilitate the progression of polymerase II through G-rich regions.
H3.3 chaperones in physiology and pathology
Due to their complex molecular mechanisms and myriad of functions, HIRA and DAXX have garnered considerable attention. Their roles in normal physiology, as well as numerous diseases, such as developmental disorders, cancer, and age-related diseases, have been extensively studied. In this section, we discuss the importance of HIRA and DAXX in disease, as well as their distinct and overlapping contributions (Fig. 4).
Developmental functions and disorders
H3.3 is essential in developmental processes, as demonstrated by the developmental retardation and early embryonic lethality of H3f3a and H3f3b double KO mice113. A lack of H3.3 results in reduced cell proliferation, increased cell death, and mitotic defects in a p53-dependent manner in mouse embryos113, and a low nucleosome turnover rate, improper lineage specification despite functional pluripotency, and upregulated expression of trophectoderm markers in mouse ESCs114. In line with this, mice lacking HIRA, DAXX, or ATRX are all embryonic lethal, demonstrating the importance of proper H3.3 distribution in development115,116. The absence of HIRA or DAXX leads to defects in oogenesis, spermatogenesis, and embryogenesis117 (Fig. 4a). Loss of ATRX results in defects in trophoblast development and the pattern of the X-inactivation center in extraembryonic tissue118. DAXX regulates the expression of PRC1 target genes119, while HIRA deposits H3.3 at bivalent promoters14, enriched with PRC2 and H3K27me3. Knockdown of H3.3 or HIRA results in decreased H3K27me3 levels and increased H3K27Ac levels, leading to activation of bivalent genes and ESC differentiation14,114.
Furthermore, the HIRA and DAXX complex is involved in multiple lineage specifications, including myogenesis, neurogenesis, and hematopoiesis. In muscle stem cells, HIRA and DAXX unidirectionally maintain muscle lineage identity (Fig. 4a). Cabin1 within the HIRA complex recruits Suv39h1, and HDACs, and inhibits myogenic genes and alternative cell fate-determining genes29,30. DAXX simultaneously inhibits E2A-dependent expression of key myogenic genes120. Upon differentiation que, HIRA and DAXX drive myogenesis. PML-NB are reduced, and DAXX is translocated to chromocenters to maintain the structural organization of the heterochromatin domain92,93. HIRA complexes undergo rearrangement to form an activator complex with p300 and/or Asf1 for terminal differentiation71. Such importance of HIRA and DAXX in muscle development provides a rationale for cardiac muscle defects associated with HIRA and DAXX (Fig. 4b). Importance of HIRA in heart physiology is evidenced by impaired heart development in HIRA KO mice, dependence of mESC cardiac differentiation on HIRA-mediated H3.3 deposition121,122, and abnormal low expression of the HIRA gene in the myocardium of patients with tetralogy of Fallot123. In addition, DAXX is associated with myocardial ischemia/reperfusion-mediated proapoptotic signaling in mice124.
During neurogenesis, both HIRA and ATRX play an essential role in maintaining a pool of neural progenitor cells (NPCs) and contribute to embryonic brain development. The involvement of HIRA in NPC self-renewal is mediated through its WD40 domain125, which is shared by the proteins crucial for brain development and neuronal connectivity126. Furthermore, ATRX depletion leads to increased cell cycle exit and premature differentiation of NPCs127, while PML is expressed in NPCs but not in differentiated neurons128. These results suggest the importance of H3.3 loading by chaperones of the PML/DAXX/ATRX complex in neurogenesis129. The importance of proper distribution of H3.3 is supported by the pathological consequences arising from deregulated H3.3 and its chaperone activities. For example, patients with de novo truncating variants of HIRA may experience neurodevelopmental disorders130. Furthermore, PML loss results in altered corticogenesis and smaller brains128. The de novo missense variants of H3F3A and H3F3B, which disrupt interactions with DNA, other histones, and histone chaperone proteins, are associated with neurodevelopmental delay and neurologic abnormalities131.
Although the functional consequences of DAXX and HIRA were concomitant in myogenesis and neurogenesis (Fig. 4a), their effects are distinct in hematopoiesis. Loss of H3.3 in hematopoietic stem cells (HSCs) downregulates the expression of stemness- and lineage-specific genes with a predominant increase in H3K27me3 levels. In contrast, H3K9me3 level are reduced in ERV repeats, and chromatin accessibility is increased in the interferon regulatory regions. Therefore, a delicate interplay between H3K27me3 and H3K9me3 marks maintains the adaptability of HSC chromatin132. Similarly, the balance between HIRA and DAXX complexes appears to be critical in the determination of the hematopoietic lineage (Fig. 4c). DAXX represses myeloid lineages133, while HIRA restricts erythroid-biased differentiation134. Mice with hematopoietic-specific deletion of HIRA show thrombocytopenia, anemia, and lymphocytopenia135. DAXX-KO mice develop neutrophilia and inflammation133. These pathological consequences highlight the critical role of the balanced regulation of H3.3 by HIRA and DAXX complexes in normal hematopoiesis and immune system development.
Cancer
Recurrent and distinct mutations in H3.3 have been implicated in cancers. These mutations are often found in the N-terminal tail of H3.3, a region enriched with PTMs. In particular, mutations of K27, G34, and K36 of H3.3 are frequently observed in various cancers. The H3.3K27M mutant is found in 78% of diffuse intrinsic pontine gliomas and, in some cases, high-grade astrocytomas136,137. The mutation in H3.3G34 affects H3.3K36 modification138,139. Interestingly, distinct substituted amino acid residues are found in specific cancers: G34V in glioma, G34R in pediatric high-grade glioma, G34W or G34L in 92% of giant cell tumors of bone140, and H3.3K36 mutation in 95% of chondroblastoma and sometimes in clear-cell chondrosarcoma. These mutations exert a profound influence on global epigenetic states despite the presence of H3.1, highlighting the critical role of H3.3 in the epigenetic landscape in cancer.
Accordingly, dysregulation of HIRA or DAXX complexes is observed in various types of cancers, such as breast, lung, prostate, colorectal, glioma, pancreatic, leukemia, prostate, gastric, ovarian, and chondrosarcoma. In contrast to development processes, altered functions of HIRA and DAXX as H3.3 histone chaperones have distinct consequences in tumor development and progression (Fig. 4d). HIRA plays oncogenic roles by depositing H3.3 in promoters related to epithelial-mesenchymal transition, metastasis and invasion in chronic myeloid leukemia, breast cancer, and prostate cancer101,141. In contrast, the incorporation of H3.3 by DAXX suppresses cancer development by maintaining telomeres and promoting the DNA damage response. Dysfunctional DAXX and ATRX result in homologous recombination of telomeres, which leads to ALT142. Consistently, DAXX and ATRX loss-of-function mutations have been reported in various ALT-positive cancers, such as pancreatic neuroendocrine tumors (PanNETs) and pediatric glioblastoma multiforme (GBM)143,144,145. In addition to telomere maintenance, loss-of-function mutations in DAXX and ATRX lead to defective silencing of retrotransposable elements, leading to chronic inflammation, myeloid malignancies, and autoimmune diseases146,147,148. Recurrent DAXX mutations are observed in thyroid carcinoma149, while DAXX degradation by SPOP contributes to kidney tumorigenesis150.
H3.3 chaperone-independent activities of HIRA and DAXX lead to quite different consequences. In contrast to the oncogenic consequences of HIRA-mediated H3.3 deposition, HIRA can function as a tumor suppressor independent of its chaperone activity. HIRA, together with ASF1, can aid in macroH2A deposition and is needed for SAHFs and cell cycle exit18,31. Involvement of HIRA in cell cycle regulation can be further inferred by cyclin/CDK2-mediated phosphorylation, and S-phase arrest upon ectopic expression of HIRA151. The activated senescence phenotype serves as a tumor-suppressive mechanism in a mouse skin cancer model152. Furthermore, the loss of HIRA activates MYC and its target genes, independent of its chaperone activity, and enhances the proliferation and invasion of fumarate hydratase deficient hereditary leiomyomatosis and renal cell carcinoma (HLRCC)153.
The chaperone-independent activity of DAXX exerts oncogenic effects, as opposed to the tumor-suppressive effects of its chaperone activity. DAXX interacts with and modulates many transcription factors. DAXX interacts with CCAAT/enhancer-binding protein beta (CEBP-b) and activates the ERK signaling pathway to induce the formation of ovarian cancer ascites154. Furthermore, DAXX functions as an anaphase-promoting complex (APC) inhibitor, promoting chromosome instability and cancer predisposition during prostate cancer development155. Highly expressed DAXX can promote cell proliferation and chemoresistance in ovarian cancer156. In addition, in prostate cancer, downregulation of the autophagy modulators DAPK3 and ULK1 by DAXX enhances tumor growth and primary prostatic malignancy157. In cancers with CENP-A overexpression, DAXX aberrantly deposits CENP-A into noncentromeric DNA, including the 8q24 locus, which can overexpress the MYC gene158.
Neurodegenerative disorders
In addition to their important roles in neuronal development, HIRA and DAXX actively participate in adult neuronal activities. Unlike other postreplicative cells, H3.3 remains highly dynamic in adult neurons, and the HIRA-dependent turnover of H3.3 is essential in neuronal plasticity159. Furthermore, DAXX promotes H3.3 loading to activate immediate early genes in the cortical neurons of the mouse CNS111. Consequently, dysregulation of HIRA has been implicated in the alteration of chromatin remodeling and gene expression patterns in Alzheimer’s disease. Likewise, abnormal DAXX activity contributes to protein aggregation and neuronal dysfunction in Parkinson’s disease160, schizophrenia161, and amyotrophic lateral sclerosis. Independent of its function as a histone chaperone, DAXX has been reported to prevent and reverse the aggregation of neurodegeneration-associated proteins162. In addition, upregulation of DAXX by the proinflammatory cytokine IFN-gamma upon tissue damage or infection regulates the population of activated microglia by mediating the apoptosis of microglia163,164. However, loss of DAXX fails to control activated microglia, contributing to the pathogenesis of neurodegenerative disorders165. Altogether, both HIRA and DAXX maintain healthy neuronal activity, and loss of function of either protein can promote the development of neurodegenerative disorders.
Senescence
Despite the limited proliferation capacity in senescent cells, the landscape of chromatin is maintained by depositing newly synthesized histones dynamically166. Histone H3.3 displaces H3.1 and H3.2 during senescence, leading to the relaxation of chromatin and transcription activation at specific loci. The active promoters in senescent cells are enriched in H4K16ac, which requires HIRA for incorporation152. In addition to HIRA, ATRX is also needed for SAHF formation. PML induced by oncogenic Ras promotes premature senescence167. In contrast, DAXX mRNA expression levels decrease with aging in various tissues, such as the kidney, heart, and cortex168. The impaired function of DAXX/ATRX in telomere maintenance results in telomere shortening and cell senescence. Furthermore, independent of its chaperone activity, DAXX suppresses p53/p21-mediated senescence in mouse ovarian epithelial cells169,170. Thus, it is likely that DAXX plays multifaceted roles in senescence, depending on its interacting proteins and cellular contexts.
Conclusions and prospects
As we explore the diverse functions of H3.3 chaperone complexes in this review, intriguing questions arise regarding the mechanisms underlying their similar but distinct actions. One intriguing question is what dictates the deposition route of H3.3 into specific chromatin domains. Determining whether the availability of H3.3 in various storage compartments could predispose its utilization in different genomic regions will help answer this question. In addition, further research is required to fully elucidate the function of H3.3-containing nucleosomes in chromatin contexts, especially where domain features are primarily attributed to histone marks. It is also of great interest to determine what intrinsic properties of H3.3-containing nucleosome enable it to function in both euchromatin and heterochromatin, thereby contributing to its adaptability in a variety of chromatin environments. Moreover, investigating the genomic and epigenomic contexts that determine the dependence of DAXX on ATRX and vice versa would shed light on the intricate interplay between the chaperone-dependent and chaperone-independent functions of these proteins in chromatin regulation.
We have highlighted the importance of the delicate equilibrium between H3.3 histone chaperones for maintaining normal physiological and cellular functions. Any disturbances to this equilibrium can result in various pathological outcomes. To fully comprehend the intricate interplay between histone chaperone complexes, additional research is needed. The development of small molecules that modulate the activities of HIRA or DAXX complexes could provide valuable insights and lead to therapeutic applications for cancer and other diseases. By addressing these questions and investigating the complex dynamics of the H3.3 landscape, new avenues will be revealed for understanding chromatin regulation and its role in health and disease.
References
Kouzarides, T. Chromatin modifications and their function. Cell 128, 693–705 (2007).
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251–260 (1997).
Millán-Zambrano, G., Burton, A., Bannister, A. J. & Schneider, R. Histone post-translational modifications—cause and consequence of genome function. Nat. Rev. Genet. 23, 563–580 (2022).
Gurard-Levin, Z. A., Quivy, J.-P. & Almouzni, G. Histone chaperones: assisting histone traffic and nucleosome dynamics. Annu. Rev. Biochem. 83, 487–517 (2014).
Hammond, C. M., Strømme, C. B., Huang, H., Patel, D. J. & Groth, A. Histone chaperone networks shaping chromatin function. Nat. Rev. Mol. Cell Biol. 18, 141–158 (2017).
Piña, B. & Suau, P. Changes in histones H2A and H3 variant composition in differentiating and mature rat brain cortical neurons. Dev. Biol. 123, 51–58 (1987).
Xu, X. et al. Stable inheritance of H3.3-containing nucleosomes during mitotic cell divisions. Nat. Commun. 13, 2514 (2022).
Hake, S. B. & Allis, C. D. Histone H3 variants and their potential role in indexing mammalian genomes: The ‘H3 barcode hypothesis’. Proc. Natl. Acad. Sci. USA 103, 6428–6435 (2006).
Liu, C. P. et al. Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX. Nat. Struct. Mol. Biol. 19, 1287–1292 (2012).
Ricketts, M. D. et al. Ubinuclein-1 confers histone H3.3-specific-binding by the HIRA histone chaperone complex. Nat. Commun. 6, 7711 (2015).
Xiong, C. et al. UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells. BMC Biol. 16, 1–18 (2018).
Chang, F. T. M. et al. CHK1-driven histone H3.3 serine 31 phosphorylation is important for chromatin maintenance and cell survival in human ALT cancer cells. Nucleic Acids Res. 43, 2603–2614 (2015).
Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C. & Allis, C. D. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl. Acad. Sci. USA 107, 14075–14080 (2010).
Goldberg, A. D. et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140, 678–691 (2010).
Cook, A. J. L., Gurard-Levin, Z. A., Vassias, I. & Almouzni, G. A specific function for the histone chaperone NASP to fine-tune a reservoir of soluble H3-H4 in the histone supply chain. Mol. Cell 44, 918–927 (2011).
Gieni, R. S., Chan, G. K. T. & Hendzel, M. J. Epigenetics regulate centromere formation and kinetochore function. J. Cell. Biochem. 104, 2027–2039 (2008).
Rai, T. S. et al. Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Mol. Cell Biol. 31, 4107–4118 (2011).
Banumathy, G. et al. Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol. Cell Biol. 29, 758–770 (2009).
Yang, J.-H. et al. Histone chaperones cooperate to mediate Mef2-targeted transcriptional regulation during skeletal myogenesis. Biochem. Biophys. Res. Commun. 407, 541–547 (2011).
Ray-Gallet, D. et al. Functional activity of the H3.3 histone chaperone complex HIRA requires trimerization of the HIRA subunit. Nat. Commun. 9, 3103 (2018).
Ricketts, M. D. & Marmorstein, R. A molecular prospective for HIRA complex assembly and H3.3-specific histone chaperone function. J. Mol. Biol. 429, 1924–1933 (2017).
Ray-Gallet, D. et al. Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol. Cell 44, 928–941 (2011).
Schneiderman, J. I., Orsi, G. A., Hughes, K. T., Loppin, B. & Ahmad, K. Nucleosome-depleted chromatin gaps recruit assembly factors for the H3.3 histone variant. Proc. Natl. Acad. Sci. USA 109, 19721–19726 (2012).
Daniel Ricketts, M. et al. The HIRA histone chaperone complex subunit UBN1 harbors H3/H4- And DNA-binding activity. J. Biol. Chem. 294, 9239–9259 (2019).
Ye, X. et al. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol. Cell 27, 183–196 (2007).
Yang, J. H. et al. Differential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch. Exp. Mol. Med. 48, e252–e252 (2016).
Lee, J. S. & Zhang, Z. O-linked N-acetylglucosamine transferase (OGT) interacts with the histone chaperone HIRA complex and regulates nucleosome assembly and cellular senescence. Proc. Natl. Acad. Sci. USA 113, E3213–E3220 (2016).
Hoang, S. M. et al. Regulation of ALT-associated homology-directed repair by polyADP-ribosylation. Nat. Struct. Mol. Biol. 27, 1152–1164 (2020).
Youn, H. D. & Liu, J. O. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13, 85–94 (2000).
Jang, H., Choi, D. E., Kim, H., Cho, E. J. & Youn, H. D. Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. J. Biol. Chem. 282, 11172–11179 (2007).
Zhang, R. et al. Formation of macroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 19–30 (2005).
Duarte, L. F. et al. Histone H3.3 and its proteolytically processed form drive a cellular senescence programme. Nat. Commun. 5, 5210 (2014).
Tagami, H., Ray-Gallet, D., Almouzni, G. & Nakatani, Y. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116, 51–61 (2004).
English, C. M., Adkins, M. W., Carson, J. J., Churchill, M. E. A. & Tyler, J. K. Structural basis for the histone chaperone activity of Asf1. Cell 127, 495–508 (2006).
English, C. M., Maluf, N. K., Tripet, B., Churchill, M. E. A. & Tyler, J. K. ASF1 binds to a heterodimer of histones H3 and H4: a two-step mechanism for the assembly of the H3-H4 heterotetramer on DNA. Biochemistry 44, 13673–13682 (2005).
Natsume, R. et al. Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4. Acta Crystallogr. A 64, C375–C375 (2008).
Torné, J. et al. Two HIRA-dependent pathways mediate H3.3 de novo deposition and recycling during transcription. Nat. Struct. Mol. Biol. 27, 1057–1068 (2020).
Song, Y. et al. Dissecting the roles of the histone chaperones reveals the evolutionary conserved mechanism of transcription-coupled deposition of H3.3. Nucleic Acids Res. 41, 5199–5209 (2013).
Grover, P., Asa, J. S. & Campos, E. I. H3-H4 histone chaperone pathways. Annu. Rev. Genet. 52, 109–130 (2018).
Elsässer, S. J. et al. DAXX envelops a histone H3.3–H4 dimer for H3.3-specific recognition. Nature 491, 560–565 (2012).
Hoelper, D., Huang, H., Jain, A. Y., Patel, D. J. & Lewis, P. W. Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX. Nat. Commun. 8, 1193 (2017).
Lin, D.-Y. et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341–354 (2006).
Aguilera, P. & López-Contreras, A. J. ATRX, a guardian of chromatin. Trends Genet. 39, 505–519 (2023).
Dhayalan, A. et al. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Hum. Mol. Genet. 20, 2195–2203 (2011).
Thiru, A. et al. Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. EMBO J. 23, 489–499 (2004).
Zeng, W., Ball, A. R. Jr & Yokomori, K. HP1: Heterochromatin binding proteins working the genome. Epigenetics 5, 287–292 (2010).
Marano, D. et al. ATRX contributes to MeCP2-mediated pericentric heterochromatin organization during neural differentiation. Int. J. Mol. Sci. 20, 5371 (2019).
Kernohan, K. D. et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev. Cell 18, 191–202 (2010).
Voon, H. P. J. et al. ATRX plays a key role in maintaining silencing at interstitial heterochromatic loci and imprinted genes. Cell Rep. 11, 405–418 (2015).
Sarma, K. et al. ATRX directs binding of PRC2 to Xist RNA and polycomb targets. Cell 159, 869–883 (2014).
Ren, W. et al. Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function. Nat. Commun. 11, 2219 (2020).
Bernardi, R. & Pandolfi, P. P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006–1016 (2007).
Delbarre, E., Ivanauskiene, K., Küntziger, T. & Collas, P. DAXX-dependent supply of soluble (H3.3–H4) dimers to PML bodies pending deposition into chromatin. Genome Res. 23, 440–451 (2013).
Ishov, A. M. et al. Pml is critical for Nd10 formation and recruits the Pml-interacting protein Daxx to this nuclear structure when modified by Sumo-1. J. Cell Biol. 147, 221–234 (1999).
Corpet, A., Olbrich, T., Gwerder, M., Fink, D. & Stucki, M. Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle 13, 249–267 (2014).
Delbarre, E. et al. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX. Genome Res. 27, 913–921 (2017).
Delbarre, E. & Janicki, S. M. Modulation of H3.3 chromatin assembly by PML: a way to regulate epigenetic inheritance. BioEssays 43, 2100038 (2021).
Carraro, M. et al. DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network. Mol. Cell 83, 1075–1092.e9 (2023).
Tafessu, A. et al. H3.3 contributes to chromatin accessibility and transcription factor binding at promoter-proximal regulatory elements in embryonic stem cells. Genome Biol. 24, 25 (2023).
Gehre, M. et al. Lysine 4 of histone H3.3 is required for embryonic stem cell differentiation, histone enrichment at regulatory regions and transcription accuracy. Nat. Genet. 52, 273–282 (2020).
Yu, G. et al. The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions. Proc. Natl. Acad. Sci. USA 118, e2114743118 (2021).
Jin, C. et al. H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat. Genet. 41, 941–945 (2009).
Hu, G. et al. H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation. Cell Stem Cell 12, 180–192 (2013).
Thakar, A. et al. H2A.Z and H3.3 histone variants affect nucleosome structure: biochemical and biophysical studies. Biochemistry 48, 10852–10857 (2009).
Chen, P. et al. H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin. Genes Dev. 27, 2109–2124 (2013).
Zhang, H. et al. RPA interacts with HIRA and regulates H3.3 deposition at gene regulatory elements in mammalian cells. Mol. Cell 65, 272–284 (2017).
Konev, A. Y. et al. CHD1 motor protein is required for deposition of histone variant H3.3 into chromatin in vivo. Science 317, 1087–1090 (2007).
Loppin, B. et al. The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature 437, 1386–1390 (2005).
Schoberleitner, I. et al. CHD1 controls H3.3 incorporation in adult brain chromatin to maintain metabolic homeostasis and normal lifespan. Cell Rep. 37, 109769 (2021).
Harada, A. et al. Chd2 interacts with H3.3 to determine myogenic cell fate. EMBO J. 31, 2994–3007 (2012).
Yang, J.-H. et al. Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition. Proc. Natl. Acad. Sci. USA 108, 85–90 (2011).
Soni, S., Pchelintsev, N., Adams, P. D. & Bieker, J. J. Transcription factor EKLF (KLF1) recruitment of the histone chaperone HIRA is essential for β-globin gene expression. Proc. Natl. Acad. Sci. USA 111, 13337–13342 (2014).
Martire, S. et al. Phosphorylation of histone H3.3 at serine 31 promotes p300 activity and enhancer acetylation. Nat. Genet. 51, 941–946 (2019).
Adam, S., Polo, S. E. & Almouzni, G. Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA. Cell 155, 94–106 (2013).
Deaton, A. M. et al. Enhancer regions show high histone H3.3 turnover that changes during differentiation. eLife 5, e15316 (2016).
Sarai, N. et al. WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition. EMBO J. 32, 2392–2406 (2013).
Guo, R. et al. BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing. Mol. Cell 56, 298–310 (2014).
Wen, H. et al. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. Nature 508, 263–268 (2014).
Armache, A. et al. Histone H3.3 phosphorylation amplifies stimulation-induced transcription. Nature 583, 852–857 (2020).
Buratowski, S. Progression through the RNA polymerase II CTD cycle. Mol. Cell 36, 541–546 (2009).
Hsin, J.-P. & Manley, J. L. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 26, 2119–2137 (2012).
Iannone, C. & Valcárcel, J. Chromatin’s thread to alternative splicing regulation. Chromosoma 122, 465–474 (2013).
Jimeno-González, S. et al. Defective histone supply causes changes in RNA polymerase II elongation rate and cotranscriptional pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 112, 14840–14845 (2015).
Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145–166 (2012).
Johnson, W. L. et al. RNA-dependent stabilization of SUV39H1 at constitutive heterochromatin. eLife 6, e25299 (2017).
Shirai, A. et al. Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly. eLife 6, e25317 (2017).
Velazquez Camacho, O. et al. Major satellite repeat RNA stabilize heterochromatin retention of Suv39h enzymes by RNA-nucleosome association and RNA:DNA hybrid formation. eLife 6, e25293 (2017).
Muchardt, C. et al. Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1 α. EMBO Rep. 3, 975–981 (2002).
Saksouk, N., Simboeck, E. & Déjardin, J. Constitutive heterochromatin formation and transcription in mammals. Epigenet. Chromatin 8, 3 (2015).
Fan, J. Y., Rangasamy, D., Luger, K. & Tremethick, D. J. H2A.Z alters the nucleosome surface to promote HP1α-mediated chromatin fiber folding. Mol. Cell 16, 655–661 (2004).
Fioriniello, S. et al. MeCP2 and major satellite forward RNA Cooperate for pericentric heterochromatin organization. Stem Cell Rep. 15, 1317–1332 (2020).
Park, J. et al. Long non-coding RNA ChRO1 facilitates ATRX/DAXX-dependent H3.3 deposition for transcription-associated heterochromatin reorganization. Nucleic Acids Res. 46, 11759–11775 (2018).
Salsman, J. et al. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres. Cell Death Dis. 8, e2724–e2724 (2017).
Brändle, F., Frühbauer, B. & Jagannathan, M. Principles and functions of pericentromeric satellite DNA clustering into chromocenters. Semin. Cell Dev. Biol. 128, 26–39 (2022).
Elsässer, S. J., Noh, K.-M., Diaz, N., Allis, C. D. & Banaszynski, L. A. Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells. Nature 522, 240–244 (2015).
Tal, A., Aguilera, J. D., Bren, I., Strauss, C. & Schlesinger, S. Differential effect of histone H3.3 depletion on retroviral repression in embryonic stem cells. Clin. Epigenet. 15, 83 (2023).
Yang, P., Wang, Y. & Macfarlan, T. S. The role of KRAB-ZFPs in transposable element repression and mammalian evolution. Trends Genet. 33, 871–881 (2017).
Groh, S. et al. Morc3 silences endogenous retroviruses by enabling Daxx-mediated histone H3.3 incorporation. Nat. Commun. 12, 5996 (2021).
Sachs, P. et al. SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells. Nat. Commun. 10, 1335 (2019).
Navarro, C., Lyu, J., Katsori, A.-M., Caridha, R. & Elsässer, S. J. An embryonic stem cell-specific heterochromatin state promotes core histone exchange in the absence of DNA accessibility. Nat. Commun. 11, 5095 (2020).
Gomes, A. P. et al. Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization. Cancer Cell 36, 402–417.e13 (2019).
Lacoste, N. et al. Mislocalization of the centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone DAXX. Mol. Cell 53, 631–644 (2014).
Fromental-Ramain, C., Ramain, P. & Hamiche, A. The Drosophila DAXX-Like protein (DLP) cooperates with ASF1 for H3.3 deposition and heterochromatin formation. Mol. Cell Biol. 37, e00597-16 (2017).
Morozov, V. M., Gavrilova, E. V., Ogryzko, V. V. & Ishov, A. M. Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions. Nucleus 3, 276–285 (2012).
Ivanauskiene, K. et al. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity. Genome Res. 24, 1584–1594 (2014).
Cohen, C. et al. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 chaperone axis. PLoS Pathog. 14, e1007313 (2018).
McFarlane, S. et al. The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection. PLoS Pathog. 15, e1007667 (2019).
Rai, T. S. et al. Histone chaperone HIRA deposits histone H3.3 onto foreign viral DNA and contributes to anti-viral intrinsic immunity. Nucleic Acids Res. 45, 11673–11683 (2017).
Kleijwegt, C. et al. Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus. eLife 12, e80156 (2023).
Zhang, M. et al. Histone chaperone HIRA complex regulates retrotransposons in embryonic stem cells. Stem Cell Res. Ther. 13, 137 (2022).
Michod, D. et al. Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation. Neuron 74, 122–135 (2012).
Levy, M. A., Kernohan, K. D., Jiang, Y. & Bérubé, N. G. ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions. Hum. Mol. Genet. 24, 1824–1835 (2015).
Jang, C.-W., Shibata, Y., Starmer, J., Yee, D. & Magnuson, T. Histone H3.3 maintains genome integrity during mammalian development. Genes Dev. 29, 1377–1392 (2015).
Banaszynski, L. A. et al. Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cells. Cell 155, 107–120 (2013).
Michaelson, J. S., Bader, D., Kuo, F., Kozak, C. & Leder, P. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13, 1918–23 (1999).
Roberts, C. et al. Targeted mutagenesis of the Hira gene results in gastrulation defects and patterning abnormalities of mesoendodermal derivatives prior to early embryonic lethality. Mol. Cell Biol. 22, 2318–28 (2002).
Rajam, S. M., Varghese, P. C. & Dutta, D. Histone chaperones as cardinal players in development. Front. Cell Dev. Biol. 10, 767773 (2022).
Garrick, D. et al. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2, e58 (2006).
Liu, Z. et al. SUMOylated PRC1 controls histone H3.3 deposition and genome integrity of embryonic heterochromatin. EMBO J. 39, e103697 (2020).
Gupta, A. et al. Daxx inhibits muscle differentiation by repressing E2A-mediated transcription. J. Cell Biochem 107, 438–447 (2009).
Dilg, D. et al. HIRA is required for heart development and directly regulates Tnni2 and Tnnt3. PLoS ONE 11, e0161096 (2016).
Saleh, R. N. M. et al. HIRA directly targets the enhancers of selected cardiac transcription factors during in vitro differentiation of mouse embryonic stem cells. Mol. Biol. Rep. 45, 1001–1011 (2018).
Ju, Z.-R., Wang, H.-J., Ma, X.-J., Ma, D. & Huang, G.-Y. HIRA gene is lower expressed in the myocardium of patients with tetralogy of Fallot. Chin. Med. J. 129, 2403–2408 (2016).
Roubille, F. et al. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury. Circulation 116, 2709–2717 (2007).
Li, Y. & Jiao, J. Histone chaperone HIRA regulates neural progenitor cell proliferation and neurogenesis via β-catenin. J. Cell Biol. 216, 1975–1992 (2017).
Kannan, M. et al. WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. Proc. Natl. Acad. Sci. USA 114, E9308–E9317 (2017).
Ritchie, K., Watson, L. A., Davidson, B., Jiang, Y. & Bérubé, N. G. ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain. Biol. Open 3, 1158–1163 (2014).
Regad, T., Bellodi, C., Nicotera, P. & Salomoni, P. The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat. Neurosci. 12, 132–140 (2009).
Salomoni, P. The PML-interacting protein DAXX: histone loading gets into the picture. Front. Oncol. 3, 152 (2013).
Jeanne, M. et al. Haploinsufficiency of the HIRA gene located in the 22q11 deletion syndrome region is associated with abnormal neurodevelopment and impaired dendritic outgrowth. Hum. Genet. 140, 885–896 (2021).
Bryant, L. et al. Histone H3.3 beyond cancer: germline mutations in histone 3 family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients. Sci. Adv. 6, eabc9207 (2020).
Guo, P. et al. Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability. Nat. Cell Biol. 24, 99–111 (2022).
Gerber, J. P. et al. Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation. Nat. Cell Biol. 23, 1224–1239 (2021).
Murdaugh, R. L. et al. The histone H3.3 chaperone HIRA restrains erythroid-biased differentiation of adult hematopoietic stem cells. Stem Cell Rep. 16, 2014–2028 (2021).
Chen, C. et al. HIRA, a DiGeorge syndrome candidate gene, confers proper chromatin accessibility on HSCs and supports all stages of hematopoiesis. Cell Rep. 30, 2136–2149.e4 (2020).
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251–253 (2012).
Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46, 462–466 (2014).
Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857–861 (2013).
Lowe, B. R. et al. Surprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail. eLife 10, e65369 (2021).
Behjati, S. et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat. Genet. 45, 1479–1482 (2013).
Majumder, A. et al. Histone chaperone HIRA dictate proliferation vs differentiation of chronic myeloid leukemia cells. FASEB Bioadv. 1, 525–537 (2019).
Clynes, D. et al. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX. Nat. Commun. 6, 7538 (2015).
Jiao, Y. et al. DAXX / ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199–1203 (2011).
Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012).
Elsässer, S. J., Allis, C. D. & Lewis, P. W. New epigenetic drivers of cancers. Science 331, 1145–1146 (2011).
Volkman, H. E. & Stetson, D. B. The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 15, 415–422 (2014).
Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012).
Dyer, M. A., Qadeer, Z. A., Valle-Garcia, D. & Bernstein, E. ATRX and DAXX: mechanisms and mutations. Cold Spring Harb. Perspect. Med. 7, a026567 (2017).
Gopal, R. K. et al. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in Hürthle cell carcinoma. Cancer Cell 34, 242–255.e5 (2018).
Li, G. et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell 25, 455–468 (2014).
Hall, C. et al. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel Cyclin-cdk2 substrate whose expression blocks S-phase progression. Mol. Cell Biol. 21, 1854–1865 (2001).
Rai, T. S. et al. HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia. Genes Dev. 28, 2712–2725 (2014).
Valcarcel-Jimenez, L. et al. HIRA loss transforms FH -deficient cells. Sci. Adv. 8, eabq8297 (2022).
Liu, S.-B., Lin, X.-P., Xu, Y., Shen, Z.-F. & Pan, W.-W. DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway. J. Ovarian Res. 11, 90 (2018).
Kwan, P. S. et al. Daxx regulates mitotic progression and prostate cancer predisposition. Carcinogenesis 34, 750–759 (2013).
Pan, W.-W. et al. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance. J. Biol. Chem. 288, 13620–13630 (2013).
Puto, L. A., Benner, C. & Hunter, T. The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancer. Oncoscience 2, 362–372 (2015).
Nye, J., Sturgill, D., Athwal, R. & Dalal, Y. HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX. PLoS ONE 13, e0205948 (2018).
Maze, I. et al. Critical role of histone turnover in neuronal transcription and plasticity. Neuron 87, 77–94 (2015).
Karunakaran, S. et al. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson’s disease: protection by α‐lipoic acid. FASEB J. 21, 2226–2236 (2007).
Subburaju, S., Coleman, A. J., Ruzicka, W. B. & Benes, F. M. Toward dissecting the etiology of schizophrenia: HDAC1 and DAXX regulate GAD67 expression in an in vitro hippocampal GABA neuron model. Transl. Psychiatry 6, e723–e723 (2016).
Huang, L. et al. DAXX represents a new type of protein-folding enabler. Nature 597, 132–137 (2021).
Streit, W. J., Walter, S. A. & Pennell, N. A. Reactive microgliosis. Prog. Neurobiol. 57, 563–581 (1999).
Yun, H. J. et al. Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J. 30, 2465–2476 (2011).
Block, M. L., Zecca, L. & Hong, J.-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57–69 (2007).
Bano, D., Piazzesi, A., Salomoni, P. & Nicotera, P. The histone variant H3.3 claims its place in the crowded scene of epigenetics. Aging 9, 602–614 (2017).
Ferbeyre, G. et al. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14, 2015–27 (2000).
Lessard-Beaudoin, M. et al. Age-dependent differential expression of death-associated protein 6 (Daxx) in various peripheral tissues and different brain regions of C57BL/6 male mice. Biogerontology 17, 817–828 (2016).
Tang, J. et al. Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8, 855–862 (2006).
Pan, W.-W. et al. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage. Gene 526, 287–294 (2013).
Acknowledgements
We thank Joo Chan Lee for help with the H3.3 nucleosome structure in Fig. 2a. All figures were created with BioRender.com. This work was supported by National Research Foundation (NRF) grants of Korea (NRF-2022R1A2C2003505 and NRF-2019R1A5A2027340 to E.-J.C. and NRF-2022R1C1C2005612 to J.C.). We also acknowledge support from the Sungkyunkwan University and the BK21 FOUR (Graduate School Innovation) funded by the Ministry of Education and NRF of Korea.
Author information
Authors and Affiliations
Contributions
E.J.C. conceptualized the manuscript. J.C. and E.J.C. conducted literature reviews, drafted the manuscript, and participated in its revision and editing. T.K. prepared the figures.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Choi, J., Kim, T. & Cho, EJ. HIRA vs. DAXX: the two axes shaping the histone H3.3 landscape. Exp Mol Med 56, 251–263 (2024). https://doi.org/10.1038/s12276-023-01145-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-023-01145-3
- Springer Nature Limited
This article is cited by
-
Multifunctional histone variants in genome function
Nature Reviews Genetics (2024)
-
Histone H3.3 lysine 9 and 27 control repressive chromatin at cryptic enhancers and bivalent promoters
Nature Communications (2024)